Optometry Times

Breaking: CMS has finalized the 2027 Medicare Physician Fee Schedule. Changes take effect Jan. 1, 2027. Read our full coverage at the links below. 👁️ hubs.li/Q04Dr7Rq0 👁️ hubs.li/Q04Dr7Rs0

Kansas, Tennessee, and Vermont expanded optometric scope in 2026, while vision plan reform and a proposed Medicare fee schedule cut affect practice management. Check out our full legislative recap here: hubs.li/Q04D5r5n0

👁️ November is Diabetic Eye Disease Awareness Month. Early diabetic eye disease may have no noticeable symptoms, so regular dilated eye exams are important. Optometrists help identify early signs and connect patients with appropriate care. #DiabeticEyeDiseaseMonth #Optometry

👁️ This week’s top stories in optometry include pipeline updates in dry eye and retinitis pigmentosa, contact lens hygiene, and more. Read the full recap here: hubs.li/Q04CWSYr0

“Is all this screen time hurting my child’s eyes?” It’s a familiar question in practice. Christina M. Danley, OD, FOVDR, on when to look deeper, plus a 60-second screen history: hubs.li/Q04Cb-q_0 #Optometry #Myopia #PediatricOptometry Sponsored by @Keplr_Vision

👁️ This week's top stories include breaking FDA approvals, insights on AI-assisted front desk management, and more. Read our full recap here: hubs.li/Q04CbpL60

BREAKING: A flurry of FDA news has hit our desks this past week across several subspecialties. Learn the latest on each development: Ryzumvi: hubs.li/Q04BCyyB0 TED: hubs.li/Q04BCyBp0 Brytly: hubs.li/Q04BCyCj0

The Sept/Oct issue of Optometry Times® is live! 👀 🔬 Oculomics in optometry 👁️ Safe contact lens habits 🐟 Omega-3s & dry eye 💡 Light-based tech for MGD 👇 Check Out the Articles From the Sept/Oct Issue on Optometry Times: hubs.li/Q04B7tPB0  #Optometry #DryEye

Highlights from AAOpt 2026! We had a wonderful time at this year's conference. To read our coverage, visit our website here: optometrytimes.com/conferenc…

That's a wrap on AAOpt Day 3! Keep an eye on our website for the full interviews: optometrytimes.com/conferenc…

Day 2 is in the books! Stay tuned for our full interviews, and keep up with our coverage here: hubs.ly/Q04y_XHX0

Day 1 of AAOpt 2026 completed ✅ Thank you to everyone who shared their insights and expertise on the exciting new developments in optometry. Stay tuned for the full interviews, and follow our AAOpt 2026 coverage here: hubs.li/Q04ySbSt0

David Webley, BSc (Hons), MCOptom, FBCLA, discussed the latest data on children's viewing and gaze behavior with SightGlass Vision's DOT spectacle lenses. Watch the full interview here: hubs.li/Q04yQFp_0

Welcome to Anaheim! We're so excited to be at this year's American Academy of Optometry Conference. For the latest insights from presenters and attendees, read our conference coverage here: hubs.ly/Q04yNQ790

👁️ This week in optometry: Major developments in the field of myopia take the spotlight. Experts also weight in on AI in practice, oculomics, and next week's AAOpt 2026 meeting. Find out what to look forward to in our recap: hubs.li/Q04ynfHK0

Leslie Scher, OD, shared her advice for performing vision screenings for athletes with intellectual disabilities at the Special Olympics. Watch the full interview here: hubs.li/Q04yh99J0 #optometry #pediatrics #specialolympics #eyecare

BREAKING: The FDA will convene an Advisory Committee on October 30, 2026, to review the SYD-101 (atropine 0.01%; Sydnexis) application for pediatric progressive myopia (PPM), according to a new announcement from Sydnexis. Read more here: hubs.li/Q04ygrw_0

As Myopia Awareness Month comes to a close, Dr Monica Jong, Head of Medical Affairs North America at EssilorLuxottica, spoke on how the Stellest lenses will contribute to the improvement of myopia preventative care. Watch the full interview: hubs.li/Q04yd1w00

👁️This week in Optometry: A recent AMA resolution backs classifying myopia as a disease, aiming to expand insurance coverage for pediatric myopia control treatments. Experts also weigh in on AI integration, comanagement, and CVI. Read our full coverage: hubs.li/Q04xW3xV0

👁️ This week on Optometry Times, leaders in the field share their perspectives on GLP-1s, neural roots of CVI, and integrating AI technology in practice. To learn more about the latest eye care developments, check out our recap: hubs.li/Q04xhX_W0